Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Stable interdomain interaction within the cytoplasmic domain of CD45 increases enzyme stability.

Felberg J, Johnson P.

Biochem Biophys Res Commun. 2000 May 10;271(2):292-8.

PMID:
10799290
2.

Subdomain X of the kinase domain of Lck binds CD45 and facilitates dephosphorylation.

Felberg J, Lefebvre DC, Lam M, Wang Y, Ng DH, Birkenhead D, Cross JL, Johnson P.

J Biol Chem. 2004 Jan 30;279(5):3455-62. Epub 2003 Nov 17.

3.

Demonstration of a direct interaction between p56lck and the cytoplasmic domain of CD45 in vitro.

Ng DH, Watts JD, Aebersold R, Johnson P.

J Biol Chem. 1996 Jan 19;271(3):1295-300.

4.

The catalytic activity of the CD45 membrane-proximal phosphatase domain is required for TCR signaling and regulation.

Desai DM, Sap J, Silvennoinen O, Schlessinger J, Weiss A.

EMBO J. 1994 Sep 1;13(17):4002-10.

6.
7.
8.

Point mutation in the second phosphatase domain of CD45 abrogates tyrosine phosphatase activity.

Ng DH, Maiti A, Johnson P.

Biochem Biophys Res Commun. 1995 Jan 5;206(1):302-9.

PMID:
7818534
9.

Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.

Tsujikawa K, Ichijo T, Moriyama K, Tadotsu N, Sakamoto K, Sakane N, Fukada S, Furukawa T, Saito H, Yamamoto H.

Mol Cancer Res. 2002 Dec;1(2):155-63.

10.

Interactions of CD45-associated protein with the antigen receptor signaling machinery in T-lymphocytes.

Veillette A, Soussou D, Latour S, Davidson D, Gervais FG.

J Biol Chem. 1999 May 14;274(20):14392-9.

11.

Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.

Poghosyan Z, Robbins SM, Houslay MD, Webster A, Murphy G, Edwards DR.

J Biol Chem. 2002 Feb 15;277(7):4999-5007. Epub 2001 Dec 10.

12.

CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling.

Irles C, Symons A, Michel F, Bakker TR, van der Merwe PA, Acuto O.

Nat Immunol. 2003 Feb;4(2):189-97. Epub 2002 Dec 23.

PMID:
12496963
13.

The MBP fusion protein restores the activity of the first phosphatase domain of CD45.

Lorenzo HK, Farber D, Germain V, Acuto O, Alzari PM.

FEBS Lett. 1997 Jul 14;411(2-3):231-5.

14.
15.
16.

Targeting of CD45 protein tyrosine phosphatase activity to lipid microdomains on the T cell surface inhibits TCR signaling.

He X, Woodford-Thomas TA, Johnson KG, Shah DD, Thomas ML.

Eur J Immunol. 2002 Sep;32(9):2578-87.

17.
18.

Structure and function of CD45: a leukocyte-specific protein tyrosine phosphatase.

Trowbridge IS, Johnson P, Ostergaard H, Hole N.

Adv Exp Med Biol. 1992;323:29-37. Review. No abstract available.

PMID:
1485564
19.

Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45.

Nam HJ, Poy F, Saito H, Frederick CA.

J Exp Med. 2005 Feb 7;201(3):441-52. Epub 2005 Jan 31. Erratum in: J Exp Med. 2005 Mar 21;201(6):1019.

20.

Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase.

Desai DM, Sap J, Schlessinger J, Weiss A.

Cell. 1993 May 7;73(3):541-54.

PMID:
8490965

Supplemental Content

Support Center